Levocetirizine

Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)

A Phase I Study of LY3471851 in Healthy Participants

ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)

The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)

To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

Phase 1 Study of Levocetirizine

Pharmacokinetic Study of Levocetirizine Oral Solution

Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics

Drug Use Investigation for XYZAL®

Anti-inflammatory H1 Antihistamines Allergic Rhinitis

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Is Levocetirizine Less Sedating Than Cetirizine?

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)